Amedisys (AMED) Tops Q3 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Amedisys Reports Third Quarter Financial Results
October 29, 2014 7:00 AM EDTBATON ROUGE, La., Oct. 29, 2014 (GLOBE NEWSWIRE) -- Amedisys, Inc. (Nasdaq: AMED), a leading home health and hospice company, today reported its financial results for the three and nine-month periods ended September 30, 2014.
Three-Month Periods Ended September 30, 2014 and 2013
After adding back for the 2014 period, $1.0 million ($0.6 million, net of income tax) or $0.02 per diluted share and for the 2013 period $145.0 million ($90.2 million, net of income tax) or $2.86 per diluted share for certain items*, our adjusted results from continuing operations were as follows: Net service revenue of $300.3 million compared to $301.3 million in 2013. Net income from... More


